Skip to content
10-Q

Quarterly Report

CONSTELLATION PHARMACEUTICALS INC

0001564590-20-021953

← back to feed
Filed
May 6, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Apr 30, 2020 41.84M sh
Long Term Debt Q1 2020 · Mar 31, 2020 $29.68M
Long Term Debt Q1 2020 · Dec 31, 2019 $29.64M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $190.46M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $334.33M
Current Liabilities Q1 2020 · Mar 31, 2020 $19.29M
Current Liabilities Q1 2020 · Dec 31, 2019 $22.76M
Total Liabilities Q1 2020 · Mar 31, 2020 $57.54M
Total Liabilities Q1 2020 · Dec 31, 2019 $61.55M
Current Assets Q1 2020 · Mar 31, 2020 $361.67M
Current Assets Q1 2020 · Dec 31, 2019 $386.99M
Total Assets Q1 2020 · Mar 31, 2020 $373.06M
Total Assets Q1 2020 · Dec 31, 2019 $399.13M
Net Income Q1 2020 · Dec 31, 2019 −$85.6M
Net Income Q1 2020 · Mar 31, 2019 −$19.43M
Capex Q1 2020 · Mar 31, 2019 $234K
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$18.33M
Stockholders Equity Q1 2020 · Mar 31, 2019 $86.08M
Stockholders Equity Q1 2020 · Dec 31, 2018 $104.16M
Sga Expense Q1 2020 · Mar 31, 2019 $4.43M
Rd Expense Q1 2020 · Mar 31, 2019 $15.68M
Operating Income Q1 2020 · Mar 31, 2019 −$20.11M